InsidersTradesSigma
Track the Carl Zeiss Meditec AG stock price and the full directors' dealings record of the company, a listed issuer based in Germany. Shares are quoted on DE DE, under the oversight of BaFin. Operating in the Health Care sector, Carl Zeiss Meditec AG has published 1 insider filings. Market capitalisation: €2.5bn. The latest transaction was disclosed on 28 May 2026 (Buy). Among the most active insiders: Kameritsch, Peter. The full history is openly available.
Analysts rate Carl Zeiss Meditec AG Hold (neutral), based on 15 analysts. Average price target: €30.05.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Carl Zeiss Meditec AG is a company specializing in medical technology, providing innovative solutions for the diagnosis and treatment of eye diseases. It is listed on the Frankfurt Stock Exchange (XETR).